Sociedad Española de Reumatología

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1136/ard.60.11.1040 The burden of musculoskeletal diseases in the general population of Spain: results from a national survey
https://doi.org/10.1136/annrheumdis-2019-215048 Classification criteria for autoinflammatory recurrent fevers
https://doi.org/10.1183/09031936.00028510 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
https://doi.org/10.1136/ard.2008.094474 Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
https://doi.org/10.1097/01.md.0000104742.42401.e2 The GLADEL Multinational Latin American Prospective Inception Cohort of 1,214 Patients With Systemic Lupus Erythematosus
https://doi.org/10.1136/annrheumdis-2019-215315 2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
https://doi.org/10.1136/ard.2009.117200 European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
https://doi.org/10.1136/annrheumdis-2018-213030 Treating juvenile idiopathic arthritis to target: recommendations of an international task force
https://doi.org/10.1016/j.gaceta.2012.12.009 Propuestas de clase social neoweberiana y neomarxista a partir de la Clasificación Nacional de Ocupaciones 2011
https://doi.org/10.1186/ar1881 Switching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year period
https://doi.org/10.1136/ard.2008.103382 Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis
https://doi.org/10.1136/ard.62.9.897 Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity
https://doi.org/10.1002/art.20252 Long‐term efficacy of therapy in patients with fibromyalgia: A physical exercise‐based program and a cognitive‐behavioral approach
https://doi.org/10.3389/fphar.2022.750507 Mechanisms of Chemotherapy-Induced Neurotoxicity
https://doi.org/10.1177/0961203307077987 Current causes of death in systemic lupus erythematosus in Europe, 2000—2004: relation to disease activity and damage accrual
https://doi.org/10.1192/bjp.bp.109.066266 TENTS guidelines: development of post-disaster psychosocial care guidelines through a Delphi process
https://doi.org/10.1136/annrheumdis-2020-218808 Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial
https://doi.org/10.1016/j.joca.2008.06.005 Ultrasound in the study and monitoring of osteoarthritis
https://doi.org/10.1177/0961203310366572 Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus
https://doi.org/10.1186/s13075-019-1808-z Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: a case–control study
https://doi.org/10.1136/bjsports-2019-101205 Exercise treatment effect modifiers in persistent low back pain: an individual participant data meta-analysis of 3514 participants from 27 randomised controlled trials
https://doi.org/10.3899/jrheum.100857 Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study
https://doi.org/10.1136/annrheumdis-2018-214697 Consensus-based recommendations for the management of juvenile localised scleroderma
https://doi.org/10.1136/annrheumdis-2017-212076 Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis
https://doi.org/10.1016/s1699-258x(06)73084-4 Documento de consenso de la Sociedad Española de Reumatología sobre la fibromialgia
https://doi.org/10.1093/rheumatology/ken205 The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry
https://doi.org/10.1016/j.reuma.2008.09.007 Validación de cuestionarios
https://doi.org/10.5860/choice.195590 Smart citizens, smarter state: the technologies of expertise and the future of governing
https://doi.org/10.1136/ard.2007.084723 Cervical interspinous bursitis in active polymyalgia rheumatica
https://doi.org/10.1136/ard.2009.125526 EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology
https://doi.org/10.1016/j.vetpar.2009.11.025 Emerging trends in the seroprevalence of canine leishmaniosis in the Madrid region (central Spain)
https://doi.org/10.1136/annrheumdis-2018-213150 Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features: results from the 5-year long-term extension of the phase III pivotal trials
https://doi.org/10.1136/ard.2009.125658 Incidence and risk of hospitalisation due to shingles and chickenpox in patients with rheumatic diseases treated with TNF antagonists
Systematic review on the safety of methotrexate in rheumatoid arthritis regarding the reproductive system (fertility, pregnancy, and breastfeeding).
https://doi.org/10.1016/j.semarthrit.2010.08.005 Cancer in Patients with Rheumatic Diseases Exposed to TNF Antagonists
https://doi.org/10.3899/jrheum.110893 Identification of the Clinical Features Distinguishing Psoriatic Arthritis and Fibromyalgia
https://doi.org/10.1016/j.autrev.2010.12.008 Development of quality indicators to evaluate the monitoring of SLE patients in routine clinical practice
https://doi.org/10.1016/s2173-5743(09)70115-7 Validation of questionnaires
https://doi.org/10.1016/j.reuma.2017.06.009 Prevalencia de enfermedades reumáticas en población adulta en España (estudio EPISER 2016). Objetivos y metodología
https://doi.org/10.1089/vbz.2010.0109 Mapping the Current Distribution and Predicted Spread of the Leishmaniosis Sand Fly Vector in the Madrid Region (Spain) Based on Environmental Variables and Expected Climate Change
https://doi.org/10.1016/j.recesp.2020.03.027 Coronavirus: la emergencia geriátrica de 2020. Documento conjunto de la Sección de Cardiología Geriátrica de la Sociedad Española de Cardiología y la Sociedad Española de Geriatría y Gerontología
https://doi.org/10.1186/s13075-018-1776-8 Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort
https://doi.org/10.1136/annrheumdis-2020-217948 Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies
https://doi.org/10.1016/j.reumae.2015.05.002 2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis
https://doi.org/10.1136/annrheumdis-2011-200302 Change in the discontinuation pattern of tumour necrosis factor antagonists in rheumatoid arthritis over 10 years: data from the Spanish registry BIOBADASER 2.0
https://doi.org/10.1016/j.reuma.2018.09.004 Recomendaciones de la Sociedad Española de Reumatología sobre osteoporosis
https://doi.org/10.1136/ard-2023-224460 Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism
https://doi.org/10.1136/annrheumdis-2013-203765 Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project
https://doi.org/10.1016/j.reuma.2020.01.008 Prevalencia de artrosis sintomática en España: Estudio EPISER2016
https://doi.org/10.1038/s41598-020-67462-z Prevalence of Sjögren’s syndrome in the general adult population in Spain: estimating the proportion of undiagnosed cases
https://doi.org/10.1177/0961203320950477 Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality
https://doi.org/10.1136/ard-2022-222835 After JAK inhibitor failure: to cycle or to switch, that is the question – data from the JAK-pot collaboration of registries
https://doi.org/10.1007/s00296-015-3273-6 Consensus of the Spanish society of pediatric rheumatology for transition management from pediatric to adult care in rheumatic patients with childhood onset
https://doi.org/10.1016/j.anpedi.2020.09.005 Documento español de consenso sobre diagnóstico, estabilización y tratamiento del síndrome inflamatorio multisistémico pediátrico vinculado a SARS-CoV-2 (SIM-PedS)
https://doi.org/10.1186/s13075-020-2121-6 Association between periodontitis and anti-citrullinated protein antibodies in rheumatoid arthritis patients: a cross-sectional study
https://doi.org/10.1016/j.reuma.2022.03.005 Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 2: tratamiento
https://doi.org/10.1016/j.reumae.2021.12.003 Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
https://doi.org/10.1136/annrheumdis-2021-eular.2645 OP0123 SAFETY PROFILE OF JAK-INHIBITORS VERSUS TNF-INHIBITORS IN REAL-WORLD CLINICAL PRACTICE: DATA FROM A MULTICENTER REGISTER
https://doi.org/10.1007/s40744-022-00446-9 Real-World Effectiveness and Treatment Retention of Secukinumab in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Descriptive Observational Analysis of the Spanish BIOBADASER Registry
https://doi.org/10.1136/ard-2023-225271 Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry
https://doi.org/10.1136/rmdopen-2023-003824 Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register
https://doi.org/10.1111/nmo.14232 Effects of two different acute and subchronic stressors on gastrointestinal transit in the rat: A radiographic analysis
https://doi.org/10.1111/nmo.14639 Radiographic and histopathological study of gastrointestinal dysmotility in lipopolysaccharide‐induced sepsis in the rat
https://doi.org/10.1016/j.reuma.2022.02.009 Recomendaciones SER-SEPAR para el manejo de la enfermedad pulmonar intersticial difusa asociada a la artritis reumatoide. Parte 1: epidemiología, factores de riesgo y pronóstico
https://doi.org/10.1186/s12245-024-00685-3 Extended reality training for mass casualty incidents: a systematic review on effectiveness and experience of medical first responders
https://doi.org/10.1016/j.semarthrit.2025.152694 Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases
https://doi.org/10.4049/jimmunol.170.4.2147 Synoviocyte-Derived CXCL12 Is Displayed on Endothelium and Induces Angiogenesis in Rheumatoid Arthritis
https://doi.org/10.1016/j.actatropica.2010.02.009 Seasonal trends and spatial relations between environmental/meteorological factors and leishmaniosis sand fly vector abundances in Central Spain
https://doi.org/10.1007/978-1-4613-8598-1_274 Takayasu Arteritis in Children
https://doi.org/10.1111/j.1399-0039.1997.tb02715.x Polymorphism at the TNF loci in rheumatoid arthritis
https://doi.org/10.1016/j.semarthrit.2007.08.006 Cancer in Rheumatoid Arthritis: Occurrence, Mortality, and Associated Factors in a South European Population
https://doi.org/10.1186/ar1779 Protective effect of vasoactive intestinal peptide on bone destruction in the collagen-induced arthritis model of rheumatoid arthritis
https://doi.org/10.2214/ajr.144.5.967 Osteoarthritis of the glenohumeral joint: a radiologic-pathologic study
https://doi.org/10.1080/08916930600622603 Survival, mortality and causes of death in inflammatory myopathies
https://doi.org/10.1016/j.reuma.2015.05.001 Actualización 2014 del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide
https://doi.org/10.1016/j.medcli.2010.11.032 Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry
https://doi.org/10.1016/j.semarthrit.2009.06.002 Survival, Causes of Death, and Risk Factors Associated With Mortality in Spanish Systemic Sclerosis Patients: Results From a Single University Hospital
https://doi.org/10.1016/j.semarthrit.2010.05.008 Systematic Review on the Effectiveness of Immunosuppressants and Biological Therapies in the Treatment of Autoimmune Posterior Uveitis
https://doi.org/10.1016/j.reuma.2012.05.006 A meta-analysis of mortality in rheumatic diseases
https://doi.org/10.1186/1756-3305-4-52 Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments
https://doi.org/10.1016/j.semarthrit.2011.05.003 Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review
https://doi.org/10.1136/ard.2010.130625 Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
https://doi.org/10.1016/j.reuma.2009.10.006 Actualización del Documento de Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide
https://doi.org/10.1016/j.semarthrit.2010.06.004 Demyelinating Disease in Patients Treated with TNF Antagonists in Rheumatology: Data from BIOBADASER, a Pharmacovigilance Database, and a Systematic Review
https://doi.org/10.1016/j.amjmed.2009.11.010 Long-term TNF-α Blockade in Patients with Amyloid A Amyloidosis Complicating Rheumatic Diseases
https://doi.org/10.1136/annrheumdis-2012-202976 Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme
https://doi.org/10.1016/j.reuma.2011.05.002 Consenso SER sobre la gestión de riesgo del tratamiento con terapias biológicas en pacientes con enfermedades reumáticas
https://doi.org/10.1007/s10067-010-1405-7 A systematic review of the effect of TNF-α antagonists on lipid profiles in patients with rheumatoid arthritis
https://doi.org/10.1186/1475-2875-8-225 Nutritional and socio-economic factors associated with Plasmodium falciparum infection in children from Equatorial Guinea: results from a nationally representative survey
https://doi.org/10.1016/j.reumae.2011.05.001 Consensus Statement of the Spanish Society of Rheumatology on Risk Management of Biologic Therapy in Rheumatic Patients
https://doi.org/10.1097/rhu.0000000000001549 Prevalence of Sarcopenia and Whole-Body Composition in Rheumatoid Arthritis
https://doi.org/10.3899/jrheum.110329 High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis
https://doi.org/10.1016/s2173-5743(08)70197-7 Responsiveness of Outcome Measures
https://doi.org/10.1097/rhu.0b013e3182314d40 An Audit of the Variability of Diagnosis and Management of Gout in the Rheumatology Setting
https://doi.org/10.1016/j.reumae.2012.04.010 Characteristics of Patients With Spondyloarthritis Followed in Rheumatology Units in Spain. emAR II Study
https://doi.org/10.1016/j.socscimed.2012.06.017 Post-disaster psychosocial services across Europe: The TENTS project
https://doi.org/10.1002/acr.23910 Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross‐Sectional Study
https://doi.org/10.1016/j.anpede.2020.09.005 Spanish consensus document on diagnosis, stabilisation and treatment of pediatric multisystem inflammatory syndrome related to SARS-CoV-2 (SIM-PedS)
https://doi.org/10.1016/j.medcli.2008.09.034 Hipertensión arterial y política de salud en España
https://doi.org/10.1016/j.reumae.2020.01.005 Prevalence of symptomatic osteoarthritis in Spain: EPISER2016 study*